Company page
Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Limited, trading under the ticker RGC, is a public company operating in the American market. With a market capitalization of approximately $5.95 billion, Regencell focuses on developing innovative bioscience solutions. The company is dedicated to advancing its research and product offerings in the bioscience sector.

- Ticker
- RGC:NASDAQ
- Asset type
- Stock
- Market cap
- $5.95B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD